Simplex Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,384
| Closed | -$25K | – | 10227 |
|
|
2023
Q3 | $25K | Sell |
1,384
-643
| -32% | -$7.27K | ﹤0.01% | 6452 |
|
|
2023
Q2 | $22K | Sell |
2,027
-32,435
| -94% | -$452K | ﹤0.01% | 6697 |
|
|
2023
Q1 | $462K | Buy |
+34,462
| New | +$596K | ﹤0.01% | 3354 |
|
|
2022
Q4 | – | Sell |
-4,036
| Closed | -$57.2K | – | 10833 |
|
|
2022
Q3 | $56K | Buy |
4,036
+2,946
| +270% | +$47.4K | ﹤0.01% | 6294 |
|
|
2022
Q2 | $15K | Sell |
1,090
-14,860
| -93% | -$238K | ﹤0.01% | 7915 |
|
|
2022
Q1 | $259K | Buy |
+15,950
| New | +$250K | ﹤0.01% | 4760 |
|
|
2021
Q1 | – | Sell |
-1,500
| Closed | -$41.8K | – | 10344 |
|
|
2020
Q4 | $37K | Hold |
1,500
| – | – | ﹤0.01% | 6480 |
|
|
2020
Q3 | $62K | Hold |
1,500
| – | – | ﹤0.01% | 5412 |
|
|
2020
Q2 | $71K | Buy |
+1,500
| New | +$116K | ﹤0.01% | 5164 |
|
|
2020
Q1 | – | Sell |
-13,634
| Closed | -$1.23M | – | 8474 |
|
|
2019
Q4 | $1.69M | Buy |
13,634
+10,975
| +413% | +$983K | ﹤0.01% | 1625 |
|
|
2019
Q3 | $176K | Buy |
+2,659
| New | +$179K | ﹤0.01% | 3699 |
|
|
2019
Q2 | – | Sell |
-18,729
| Closed | -$1.68M | – | 8006 |
|
|
2019
Q1 | $2.1M | Buy |
18,729
+14,498
| +343% | +$1.58M | 0.01% | 1337 |
|
|
2018
Q4 | $426K | Sell |
4,231
-7,271
| -63% | -$754K | ﹤0.01% | 2380 |
|
|
2018
Q3 | $1.45M | Buy |
11,502
+5,299
| +85% | +$561K | ﹤0.01% | 1524 |
|
|
2018
Q2 | $520K | Sell |
6,203
-1,728
| -22% | -$127K | ﹤0.01% | 2425 |
|
|
2018
Q1 | $487K | Buy |
7,931
+4,075
| +106% | +$246K | 0.02% | 730 |
|
|
2017
Q4 | $225K | Buy |
+3,856
| New | +$243K | 0.01% | 1188 |
|
|
2017
Q3 | – | Sell |
-3,448
| Closed | -$371K | – | 6851 |
|
|
2017
Q2 | $417K | Sell |
3,448
-1,999
| -37% | -$232K | 0.02% | 752 |
|
|
2017
Q1 | $616K | Sell |
5,447
-6,172
| -53% | -$721K | 0.03% | 574 |
|
|
2016
Q4 | $1.26M | Buy |
+11,619
| New | +$1.38M | 0.08% | 229 |
|
|
2016
Q3 | – | Sell |
-16,469
| Closed | -$2.6M | – | 6637 |
|
|
2016
Q2 | $2.35M | Buy |
+16,469
| New | +$2.4M | 0.16% | 119 |
|
|
2016
Q1 | – | Sell |
-4,899
| Closed | -$578K | – | 6433 |
|
|
2015
Q4 | $731K | Buy |
4,899
+1,551
| +46% | +$263K | 0.06% | 294 |
|
|
2015
Q3 | $555K | Sell |
3,348
-501
| -13% | -$110K | 0.04% | 408 |
|
|
2015
Q2 | $929K | Sell |
3,849
-4,080
| -51% | -$1.09M | 0.08% | 231 |
|
|
2015
Q1 | $2.24M | Buy |
+7,929
| New | +$1.72M | 0.26% | 75 |
|
Simplex Trading's ICPT Position: Q4 2023 in Review
Simplex Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 1,384 shares — an estimated $25K sold.
Simplex Trading first reported a position in ICPT in Q1 2015 and held it in 25 quarters. The position peaked at $2.35M in Q2 2016. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Simplex Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Simplex Trading sold 1,384 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $25K.
- Simplex Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 25 quarters.
- Simplex Trading's Intercept Pharmaceuticals, Inc. position peaked at $2.35M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.